Literature DB >> 19369515

Burkholderia mallei cellular interactions in a respiratory cell model.

Gregory C Whitlock1,2, Gustavo A Valbuena3, Vsevolod L Popov3, Barbara M Judy4, D Mark Estes5,4,2, Alfredo G Torres5,3,2.   

Abstract

Burkholderia mallei is a facultative intracellular pathogen that survives and replicates in phagocytic cell lines. The bacterial burden recovered from naïve BALB/c mice infected by intranasal delivery indicated that B. mallei persists in the lower respiratory system. To address whether B. mallei invades respiratory non-professional phagocytes, this study utilized A549 and LA-4 respiratory epithelial cells and demonstrated that B. mallei possesses the capacity to adhere poorly to, but not to invade, these cells. Furthermore, it was found that B. mallei was taken up by the murine alveolar macrophage cell line MH-S following serum coating, an attribute suggestive of complement- or Fc receptor-mediated uptake. Invasion/intracellular survival assays of B. mallei-infected MH-S cells demonstrated decreased intracellular survival, whilst a type III secretion system effector bopA mutant strain survived longer than the wild-type. Evaluation of the potential mechanism(s) responsible for efficient clearing of intracellular organisms demonstrated comparable levels of caspase-3 in both the wild-type and bopA mutant with characteristics consistent with apoptosis of infected MH-S cells. Furthermore, challenge of BALB/c mice with the bopA mutant by the intranasal route resulted in increased survival. Overall, these data suggest that B. mallei induces apoptotic cell death, whilst the BopA effector protein participates in intracellular survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369515      PMCID: PMC2887548          DOI: 10.1099/jmm.0.007724-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  42 in total

Review 1.  The induction of apoptosis by bacterial pathogens.

Authors:  Y Weinrauch; A Zychlinsky
Journal:  Annu Rev Microbiol       Date:  1999       Impact factor: 15.500

2.  Glanders in a military research microbiologist.

Authors:  A Srinivasan; C N Kraus; D DeShazer; P M Becker; J D Dick; L Spacek; J G Bartlett; W R Byrne; D L Thomas
Journal:  N Engl J Med       Date:  2001-07-26       Impact factor: 91.245

3.  Infection of murine macrophage cell lines by Legionella pneumophila.

Authors:  Ling Yan; Jeffrey D Cirillo
Journal:  FEMS Microbiol Lett       Date:  2004-01-15       Impact factor: 2.742

4.  Shigella flexneri induces apoptosis in infected macrophages.

Authors:  A Zychlinsky; M C Prevost; P J Sansonetti
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

5.  Shigella flexneri Interactions with the Basolateral Membrane Domain of Polarized Model Intestinal Epithelium: Role of Lipopolysaccharide in Cell Invasion and in Activation of the Mitogen-Activated Protein Kinase ERK.

Authors:  Henrik Köhler; Sonia P Rodrigues; Beth A McCormick
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  IcsB, secreted via the type III secretion system, is chaperoned by IpgA and required at the post-invasion stage of Shigella pathogenicity.

Authors:  Michinaga Ogawa; Toshihiko Suzuki; Ichiro Tatsuno; Hiroyuki Abe; Chihiro Sasakawa
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

7.  Inflammation patterns induced by different Burkholderia species in mice.

Authors:  W Joost Wiersinga; Alex F de Vos; Regina de Beer; Catharina W Wieland; Joris J T H Roelofs; Donald E Woods; Tom van der Poll
Journal:  Cell Microbiol       Date:  2007-07-20       Impact factor: 3.715

8.  The role of macrophages in particle translocation from lungs to lymph nodes.

Authors:  A G Harmsen; B A Muggenburg; M B Snipes; D E Bice
Journal:  Science       Date:  1985-12-13       Impact factor: 47.728

9.  Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant.

Authors:  Joanne M Stevens; Ricky L Ulrich; Lowrie A Taylor; Michael W Wood; David Deshazer; Mark P Stevens; Edouard E Galyov
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

10.  Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.

Authors:  Mark P Stevens; Ashraful Haque; Timothy Atkins; Jim Hill; Michael W Wood; Anna Easton; Michelle Nelson; Cindy Underwood-Fowler; Richard W Titball; Gregory J Bancroft; Edouard E Galyov
Journal:  Microbiology (Reading)       Date:  2004-08       Impact factor: 2.777

View more
  18 in total

1.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

2.  Live Vaccination Generates Both Disease Tolerance and Host Resistance During Chronic Pulmonary Infection With Highly Virulent Francisella tularensis SchuS4.

Authors:  Alicia M Soucy; Gregory J Hurteau; Dennis W Metzger
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

3.  Burkholderia mallei and Burkholderia pseudomallei stimulate differential inflammatory responses from human alveolar type II cells (ATII) and macrophages.

Authors:  Richard Lu; Vsevolod Popov; Jignesh Patel; Tonyia Eaves-Pyles
Journal:  Front Cell Infect Microbiol       Date:  2012-12-28       Impact factor: 5.293

4.  Strategies for Intracellular Survival of Burkholderia pseudomallei.

Authors:  Elizabeth M Allwood; Rodney J Devenish; Mark Prescott; Ben Adler; John D Boyce
Journal:  Front Microbiol       Date:  2011-08-22       Impact factor: 5.640

5.  In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model.

Authors:  Shane Massey; Katie Johnston; Tiffany M Mott; Barbara M Judy; Brian H Kvitko; Herbert P Schweizer; D Mark Estes; Alfredo G Torres
Journal:  Front Microbiol       Date:  2011-08-26       Impact factor: 5.640

6.  Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.

Authors:  David P AuCoin; Dana E Reed; Nicole L Marlenee; Richard A Bowen; Peter Thorkildson; Barbara M Judy; Alfredo G Torres; Thomas R Kozel
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

7.  Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.

Authors:  Shane Massey; Linsey A Yeager; Carla A Blumentritt; Sudhamathi Vijayakumar; Elena Sbrana; Johnny W Peterson; Trevor Brasel; James W LeDuc; Janice J Endsley; Alfredo G Torres
Journal:  Sci Rep       Date:  2014-03-07       Impact factor: 4.379

8.  Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions.

Authors:  Vesna Memisević; Nela Zavaljevski; Rembert Pieper; Seesandra V Rajagopala; Keehwan Kwon; Katherine Townsend; Chenggang Yu; Xueping Yu; David DeShazer; Jaques Reifman; Anders Wallqvist
Journal:  Mol Cell Proteomics       Date:  2013-06-24       Impact factor: 5.911

9.  Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak.

Authors:  Muhammad Saqib; Ghulam Muhammad; Abeera Naureen; Muhammad H Hussain; M Nadeem Asi; M Khalid Mansoor; Mehdi Toufeer; Iahtasham Khan; Heinrich Neubauer; Lisa D Sprague
Journal:  BMC Vet Res       Date:  2012-11-07       Impact factor: 2.741

10.  Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.

Authors:  Eric R Lafontaine; Shawn M Zimmerman; Teresa L Shaffer; Frank Michel; Xiudan Gao; Robert J Hogan
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.